← Evidence map

ArticleTranslational research : the journal of laboratory and clinical medicine2021

The selective PPAR-delta agonist seladelpar reduces ethanol-induced liver disease by restoring gut barrier function and bile acid homeostasis in mice.

Huikuan Chu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

18 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32553670